AMG:ETR
Amgen Inc
387,30 €
arrow_upward
+1,75%(+6,65) 1D
20 tet, 5:35:54 m.d., GMT+2 · EUR
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për AMG...
Hap
380,90 €
I lartë
387,85 €
I ulët
380,00 €
Kapitalizimi i tregut
237,31 mld
Vëllimi mesatar
602,00
Vëllimi
147,00
Maksimumi 52-javor
392,85 €
Minimumi 52-javor
247,65 €
Numri i punonjësve
32 mijë
Hap
380,90 €
I lartë
387,85 €
I ulët
380,00 €
Kapitalizimi i tregut
237,31 mld
Vëllimi mesatar
602,00
Vëllimi
147,00
Maksimumi 52-javor
392,85 €
Minimumi 52-javor
247,65 €
Numri i punonjësve
32 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Investing.com
·
1 orë më parë
Amgen, Equifax among market cap stock movers on Tuesday
Investing.com
·
6 orë më parë
Amgen, AstraZeneca report positive trial results for Tezspire in EoE
Stock Titan
·
7 orë më parë
Swallowing symptoms improved through 52 weeks in Amgen’s esophagus-inflammation trial.
ad-hoc-news.de
·
10 orë më parë
Cantor Fitzgerald raises target for Amgen stock from USD 400 to USD 440
Profili
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Rreth Amgen Inc
Drejtori ekzekutivRobert A. Bradway
Punonjësit31,5 mijë
Themeluar më1980
SeliaThousand Oaks, Kalifornia, Shtetet e Bashkuara të Amerikës
Sektori-
Uebsajtiamgen.com